| First Author | Foxman EF | Year | 2015 |
| Journal | Proc Natl Acad Sci U S A | Volume | 112 |
| Issue | 3 | Pages | 827-32 |
| PubMed ID | 25561542 | Mgi Jnum | J:219194 |
| Mgi Id | MGI:5619870 | Doi | 10.1073/pnas.1411030112 |
| Citation | Foxman EF, et al. (2015) Temperature-dependent innate defense against the common cold virus limits viral replication at warm temperature in mouse airway cells. Proc Natl Acad Sci U S A 112(3):827-32 |
| abstractText | Most isolates of human rhinovirus, the common cold virus, replicate more robustly at the cool temperatures found in the nasal cavity (33-35 degrees C) than at core body temperature (37 degrees C). To gain insight into the mechanism of temperature-dependent growth, we compared the transcriptional response of primary mouse airway epithelial cells infected with rhinovirus at 33 degrees C vs. 37 degrees C. Mouse airway cells infected with mouse-adapted rhinovirus 1B exhibited a striking enrichment in expression of antiviral defense response genes at 37 degrees C relative to 33 degrees C, which correlated with significantly higher expression levels of type I and type III IFN genes and IFN-stimulated genes (ISGs) at 37 degrees C. Temperature-dependent IFN induction in response to rhinovirus was dependent on the MAVS protein, a key signaling adaptor of the RIG-I-like receptors (RLRs). Stimulation of primary airway cells with the synthetic RLR ligand poly I:C led to greater IFN induction at 37 degrees C relative to 33 degrees C at early time points poststimulation and to a sustained increase in the induction of ISGs at 37 degrees C relative to 33 degrees C. Recombinant type I IFN also stimulated more robust induction of ISGs at 37 degrees C than at 33 degrees C. Genetic deficiency of MAVS or the type I IFN receptor in infected airway cells permitted higher levels of viral replication, particularly at 37 degrees C, and partially rescued the temperature-dependent growth phenotype. These findings demonstrate that in mouse airway cells, rhinovirus replicates preferentially at nasal cavity temperature due, in part, to a less efficient antiviral defense response of infected cells at cool temperature. |